Traditionally, studying macromolecules and biomolecular assemblies required scientists to perform rigorous and time-consuming wet experiments. Three years ago, AlphaFold2 (AF2), and shortly after RoseTTAFold (RF), completely changed this by achieving experimental-level accuracy of protein structure prediction.
The release of AF2 undoubtedly revolutionized structural biology, enabling improved structural hypothesis generation and providing a launching pad for new AF2-based tools. However, the capabilities of AF2 and later tools have been limited to the prediction of solely polypeptide chains.
RoseTTAFold All-Atom (RFAA) is a next-generation method that builds on the achievement of AF2 and RF to enable the prediction of biomolecular complexes. RF-AA is capable of predicting the structures of all atoms of a biological unit, including:
The complex network of biological activities within cells is rarely limited to isolated protein function. Proteins interact extensively, forming assemblies with each other for signaling, interacting with DNA and RNA to manage gene expression, and binding to small molecules to drive metabolism and communication. Until RFAA, accurately modeling these intricate interactions had remained a significant hurdle despite the impressive successes in predicting protein-only structures.
RFAA, alongside its companion model RFdiffusion All-Atom (RFdiffusionAA), unlocks the ability to model and design these complex biomolecular assemblies with remarkable accuracy. This has far-reaching implications, including:
Paper: Generalized biomolecular modeling and design with RoseTTAFold All-Atom
GitHub: https://github.com/baker-laboratory/RoseTTAFold-All-Atom
We are excited to announce that RoseTTAFold All-Atom (RFAA) is now seamlessly integrated into the Genophore Platform, enhancing protein design and biologics discovery workflows. This integration allows researchers to leverage the powerful AI-driven capabilities of RFAA directly within their existing Genophore pipelines, streamlining the process of designing and analyzing complex biomolecular assemblies.
Key Features of the Integration:
In addition to the integrated solution within Genophore, we are pleased to offer a stand-alone version of RFAA for those who prefer or require a separate deployment. This version provides the full suite of RFAA's capabilities, ensuring flexibility and adaptability to diverse research needs.
Get Started Today:
By integrating RFAA with Genophore and offering a stand-alone version, we aim to empower the scientific community and therapeutics discovery scientists with versatile tools to advance research in structural biology, drug discovery, synthetic biology, and beyond. Visit our AI-powered capabilities page for more information, documentation, and support.